EP 107 (Acetazolamide extended release 500 mg)
Pill imprint EP 107 has been identified as Acetazolamide extended release 500 mg.
Acetazolamide is used in the treatment of mountain sickness / altitude sickness; pseudotumor cerebri; glaucoma; hydrocephalus; edema (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- EP 107
- 500 mg
- Orange & White
- 25.00 mm
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
Carbonic anhydrase inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Zydus Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- ammonio methacrylate copolymer type A
ammonio methacrylate copolymer type B
FD&C Yellow No. 6
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|68084-0401||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about acetazolamide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.